Novo Nordisk A/S (NVO)
132.91
+1.02
(+0.77%)
USD |
NYSE |
May 20, 16:00
133.60
+0.69
(+0.52%)
Pre-Market: 04:57
Novo Nordisk Non-Current Accrued Expenses (Quarterly)
Non-Current Accrued Expenses (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Non-Current Accrued Expenses (Quarterly) Data
Date | Value |
---|
Non Current Accrued Expenses Definition
Non Current Accrued Expenses are expenses that a company has incurred that will be paid back more than 12 months in the future. Non Current Accrued expenses are liabilities on the company’s balance sheet.
Non-Current Accrued Expenses (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Non-Current Accrued Expenses (Quarterly) Benchmarks
Amgen Inc | -- |
AstraZeneca PLC | -- |
GSK PLC | -- |
Eli Lilly and Co | -- |
Viking Therapeutics Inc | -- |